Impact of concomitant cardiovascular therapies on efficacy and safety of relugolix verus leuprolide in men with advanced prostate cancer: Subgroup analysis from the phase 3 HERO study.
暂无分享,去创建一个
D. George | N. Shore | D. Saltzstein | R. Tutrone | S. Hanson | F. Saad | M. Cookson | B. Mehlhaff | B. Brown | S. Lu | Jina Lee